Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications
| Brand name | VIORELE |
| Generic name | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL |
| Distributed by / for | Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430 |
| NDC | 68462-318-29 |
| Full product label | Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Blisters each containing 28 Tablets, Rx only, 28 day Regimen, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430, NDC 68462-318-29. |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
| Distribution | US Nationwide. |
| Quantity | 26,928 packs |
| Recall initiated | 2025-09-03 |
| Report date | 2025-10-22 |
| Recall completed | — |
| Recall number | D-0021-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Mahwah NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗